Respiratory Infection Antigen Combo Test Kit is a rapid lateral flow immunoassay designed for simultaneous qualitative detection of SARS-CoV-2, Influenza A, and Influenza B viral antigens from shallow nasal swab samples. Respiratory Infection Antigen Combo Test Kit enables differential diagnosis of three major respiratory pathogens in a single test, providing results within minutes for early intervention. Respiratory Infection Antigen Combo Test Kit is developed for home use by individuals without medical training, supporting timely decision-making in resource-limited or non-clinical settings.Key Features & Advantages
Triple Target Detection: Identifies SARS-CoV-2 (including variants: Alpha, Delta, Omicron BA.4/BA.5, CH.1.1, EG.5, JN.1, XDV.1) and Influenza A/B strains (H1N1, H3N2, H1N1pdm09, Yamagata, Victoria) with one swab.
High Accuracy & Efficiency: Demonstrates >98% sensitivity for early infection detection (SARS-CoV-2 within 7 days, Influenza A/B within 4 days of symptom onset), reducing false negatives.
Rapid Results: Clear visual results within 8 minutes, allowing quick distinction between viruses with overlapping symptoms (e.g., fever, cough) for appropriate treatment.
User-Centered Design: Painless shallow nasal swabbing suitable for adults and children; no instruments or specialized training required.
Cost-Effective Surveillance: Eliminates need for multiple tests or lab delays, ideal for households, schools, or workplaces during peak infection seasons.
Application Scenarios
Seasonal Outbreaks: Critical for flu seasons (Jan-Apr, Jul-Aug) and COVID-19 surges to differentiate pathogens.
High-Risk Settings: Protects vulnerable groups (immunocompromised individuals, elderly, children) in schools, hospitals, nursing homes.
Home Self-Testing: Enables families to screen symptomatic members promptly, minimizing community transmission.
Travel or Public Events: Provides pre-screening assurance for gatherings or international travel compliance.
Clinical ValueBy distinguishing SARS-CoV-2 from influenza infections early, the kit helps avoid inappropriate antibiotic use, supports targeted antiviral treatment (e.g., Tamiflu for influenza), and guides isolation protocols. Its reliability with circulating variants ensures relevance in evolving pandemic landscapes. Results should be correlated with clinical symptoms and epidemiological data; positive outcomes warrant confirmation through molecular tests when needed.Operational Simplicity
Collect sample via painless shallow nasal swab.
Insert swab into extraction buffer tube.
Apply solution to test cartridge.
Read results at 8 minutes—distinct lines indicate specific viruses.
This all-in-one diagnostic tool empowers public health management through accessibility, speed, and precision, bridging gaps between clinical testing and community-level protection.
Specification
Shelf Life
24 months
Keyword
Respiratory Infection Antigen Combo Test Kit
Usage
Professional Testing
Application
Home Hospital
Product tags
Send your message to this supplier
Send Now
Submission successful!
Respiratory Infection Antigen Combo Test Kit with 98% Accuracy and 8 Mins Test Time Using Colloidal Gold Method